Oxaliplatin-related neurotoxicity: interest of calcium-magnesium infusion and no impact on its efficacy.
Gamelin
Laurence
L
Boisdron-Celle
Michèle
M
Morel
Alain
A
Poirier
Anne Lise
AL
Berger
Virginie
V
Gamelin
Erick
E
Tournigand
Christophe
C
de Gramont
Aimery
A
D000970:Antineoplastic Agents / Q000009:adverse effects*; D002118:Calcium / Q000008:administration & dosage*; D015179:Colorectal Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000556:secondary; D006801:Humans; D007262:Infusions, Intravenous; D008274:Magnesium / Q000008:administration & dosage*; D015337:Multicenter Studies as Topic; D020258:Neurotoxicity Syndromes / Q000209:etiology*; D009944:Organoplatinum Compounds / Q000009:adverse effects*; D000077150:Oxaliplatin; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic
D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; D000077150:Oxaliplatin; D008274:Magnesium; D002118:Calcium